Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

ExoAtlet-II

K-Number: K201473 · 2021-07-16

Decision Date2021-07-16
Product CodePHL
Advisory CommitteePM
DecisionSubstantially Equivalent

Device Summary

ExoAtlet-II is the device name listed in this FDA 510(k) record. The listed applicant is Exoatlet Asia Co. , Ltd.. It received FDA 510(k) clearance on 2021-07-16 under 510(k) number K201473. The device is classified under product code PHL. It was reviewed by the PM advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the ExoAtlet-II?

ExoAtlet-II is a medical device that received FDA 510(k) clearance on 2021-07-16. The listed applicant is Exoatlet Asia Co. , Ltd.. The 510(k) number is K201473.

When did ExoAtlet-II receive FDA 510(k) clearance?

ExoAtlet-II received FDA 510(k) clearance on 2021-07-16, under 510(k) number K201473.

Who is the listed applicant for ExoAtlet-II?

The FDA 510(k) record lists Exoatlet Asia Co. , Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for ExoAtlet-II?

The FDA product code for ExoAtlet-II is PHL.

Related Devices (Code: PHL)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.